|
122 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
12 Trials |
|
2436 News |
|
| «12...56789101112131415...4950» |
- | Trial completion, Combination therapy: Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults (clinicaltrials.gov) - Feb 1, 2016
P3, N=1864, Completed, Sponsor: AIDS Clinical Trials Group
Active, not recruiting --> Completed
- | nevirapine / Generic mfg.
Trial completion, Combination therapy: OCTANE: NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission (clinicaltrials.gov) - Feb 1, 2016
P3, N=745, Completed, Sponsor: AIDS Clinical Trials Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: AIHIV: Peripheral Arterial Insufficiency Associated With HIV/AIDS (clinicaltrials.gov) - Jan 29, 2016
P=N/A, N=206, Completed, Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Active, not recruiting --> Completed Recruiting --> Completed
- zidovudine / Generic mfg., nevirapine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Enrollment change: PHPT-5: Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand (clinicaltrials.gov) - Jan 28, 2016
P3, N=435, Terminated, Sponsor: Institut de Recherche pour le Developpement
Recruiting --> Completed N=2097 --> 435
- || darunavir/ritonavir / Generic mfg.
Trial primary completion date: DUAL: Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject (clinicaltrials.gov) - Jan 25, 2016
P4, N=256, Active, not recruiting, Sponsor: Fundacion SEIMC-GESIDA
N=2097 --> 435 Trial primary completion date: Dec 2015 --> Apr 2016
- Enrollment open, Trial primary completion date: Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women (clinicaltrials.gov) - Jan 21, 2016
P=N/A, N=500, Recruiting, Sponsor: Duke University
Trial primary completion date: Dec 2015 --> Apr 2016 Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
- Trial primary completion date: Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women (clinicaltrials.gov) - Jan 17, 2016
P=N/A, N=288, Recruiting, Sponsor: FHI 360
Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Apr 2017 --> Apr 2018
- Fluzone High-Dose Quadrivalent (influenza vaccine) / Evotec, Sanofi
Trial primary completion date: Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults (clinicaltrials.gov) - Jan 17, 2016
P2, N=360, Active, not recruiting, Sponsor: University of Colorado, Denver
Trial primary completion date: Apr 2017 --> Apr 2018 Trial primary completion date: Dec 2015 --> Mar 2016
- || lopinavir/ritonavir / Generic mfg.
Trial primary completion date, Adherence: Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program (clinicaltrials.gov) - Jan 17, 2016
P=N/A, N=165, Active, not recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Dec 2015 --> Sep 2016
- Trial primary completion date: LINC: Linking Infectious and Narcology Care in Russia (clinicaltrials.gov) - Jan 17, 2016
P=N/A, N=349, Active, not recruiting, Sponsor: Boston Medical Center
Trial primary completion date: Dec 2015 --> Sep 2016 Trial primary completion date: Sep 2015 --> Mar 2016
- methamphetamine / Generic mfg.
Trial primary completion date: Reduction of Drug Use and HIV Risk Among Out-of-Treatment Methamphetamine Users (clinicaltrials.gov) - Jan 17, 2016
P=N/A, N=450, Recruiting, Sponsor: University of Colorado, Denver
Trial primary completion date: Sep 2015 --> Mar 2016 Trial primary completion date: Dec 2015 --> Mar 2016
- Trial completion, Enrollment change: Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies (clinicaltrials.gov) - Jan 16, 2016
P=N/A, N=299038, Completed, Sponsor: HIV Prevention Trials Network
Trial primary completion date: Dec 2015 --> Mar 2016 Recruiting --> Completed | N=22000 --> 299038
- Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) / Gilead, Japan Tobacco
Enrollment closed: PHI04: Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet (clinicaltrials.gov) - Jan 15, 2016
P3, N=30, Active, not recruiting, Sponsor: Duke University
Recruiting --> Completed | N=22000 --> 299038 Recruiting --> Active, not recruiting
- Trial completion: Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=30, Completed, Sponsor: Clara Lehmann
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Hiltonol (poly-ICLC) / Oncovir
Enrollment closed, Enrollment change, Trial primary completion date: Enhancement by Poly-ICLC During HIV-1 Infection (clinicaltrials.gov) - Jan 15, 2016
P1/2, N=15, Active, not recruiting, Sponsor: Nina Bhardwaj
Recruiting --> Completed Recruiting --> Active, not recruiting | N=20 --> 15 | Trial primary completion date: Dec 2016 --> Aug 2016
- || lopinavir/ritonavir / Generic mfg.
Trial initiation date, Combination therapy: PROTEKT: Kaletra in Combination With Antiretroviral Agents (clinicaltrials.gov) - Jan 11, 2016
P=N/A, N=450, Active, not recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Recruiting --> Active, not recruiting | N=20 --> 15 | Trial primary completion date: Dec 2016 --> Aug 2016 Initiation date: Jun 2006 --> Sep 2008
- Rituxan (rituximab) / Roche
Enrollment closed, Trial primary completion date: High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk (clinicaltrials.gov) - Jan 7, 2016
P2, N=43, Active, not recruiting, Sponsor: Azienda Ospedaliera Spedali Civili di Brescia
Initiation date: Jun 2006 --> Sep 2008 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2012 --> May 2016
- Isentress (raltegravir) / Merck (MSD)
Trial completion, Trial primary completion date, Combination therapy: Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-na (clinicaltrials.gov) - Jan 6, 2016
P4, N=107, Completed, Sponsor: Taipei Veterans General Hospital, Taiwan
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2012 --> May 2016 Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Dec 2015
- | Trial completion: STRIDE: Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis (clinicaltrials.gov) - Jan 5, 2016
P4, N=809, Completed, Sponsor: AIDS Clinical Trials Group
Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Dec 2015 Active, not recruiting --> Completed
- Trial primary completion date, IO biomarker: Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=629, Active, not recruiting, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Mar 2016
- Trial completion, Trial primary completion date, Adherence: RSAD-VIH-11: HIV Disclosure and Medication Adherence, a Pilot Study (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=120, Completed, Sponsor: Policlinique M
Trial primary completion date: Sep 2015 --> Mar 2016 Enrolling by invitation --> Completed | Trial primary completion date: Nov 2012 --> Jun 2013
- Trial completion, Adherence: Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women (clinicaltrials.gov) - Dec 23, 2015
P=N/A, N=26, Completed, Sponsor: Policlinique M
Enrolling by invitation --> Completed | Trial primary completion date: Nov 2012 --> Jun 2013 Recruiting --> Completed
- Trial completion: Treatment Advocacy Intervention for HIV-Positive African Americans (clinicaltrials.gov) - Dec 19, 2015
P2, N=216, Completed, Sponsor: Children's Hospital Boston
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: BRYOLAT: Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment (clinicaltrials.gov) - Dec 18, 2015
P1, N=12, Completed, Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Oct 2015 --> Jan 2015
- Trial completion: Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence (clinicaltrials.gov) - Dec 14, 2015
P=N/A, N=20, Completed, Sponsor: VA Eastern Colorado Health Care System
Active, not recruiting --> Completed | Trial primary completion date: Oct 2015 --> Jan 2015 Active, not recruiting --> Completed
- | Trial completion: Transfusion Infections Pediatric Prospective Study (TRIPPS) (clinicaltrials.gov) - Dec 14, 2015
P=N/A, N=600, Completed, Sponsor: Naomi Luban
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Vyrologix (leronlimab) / CytoDyn, Vyera Pharma, amfAR
Trial completion: Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers (clinicaltrials.gov) - Dec 13, 2015
P1, N=20, Completed, Sponsor: CytoDyn, Inc.
No longer recruiting --> Completed No longer recruiting --> Completed
- Enrollment closed: HandiVIH: Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=1610, Active, not recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
No longer recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| lamivudine / Generic mfg.
Enrollment closed, Trial primary completion date, Head-to-Head: MOBIDIP: Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa (clinicaltrials.gov) - Dec 10, 2015
P3, N=265, Active, not recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Dec 2016
- ||||||| ledipasvir/sofosbuvir / Generic mfg.
Trial completion: Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection (clinicaltrials.gov) - Dec 10, 2015
P3, N=335, Completed, Sponsor: Gilead Sciences
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Dec 2016 Active, not recruiting --> Completed
- Trial completion: Assessing the Safety of Dapivirine Gel and Film Formulations (clinicaltrials.gov) - Dec 10, 2015
P1, N=60, Completed, Sponsor: International Partnership for Microbicides, Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- Biomarker, Trial completion: Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study (clinicaltrials.gov) - Dec 9, 2015
P=N/A, N=685, Completed, Sponsor: Columbia University
Recruiting --> Completed Recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV (clinicaltrials.gov) - Dec 7, 2015
P=N/A, N=16, Completed, Sponsor: University of Miami
Recruiting --> Completed Recruiting --> Completed | N=80 --> 16 | Trial primary completion date: Jun 2017 --> Nov 2015
- | Tivicay (dolutegravir) / ViiV Healthcare, Isentress (raltegravir) / Merck (MSD)
Trial completion, IO biomarker: Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults (clinicaltrials.gov) - Dec 5, 2015
P4, N=20, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Completed | N=80 --> 16 | Trial primary completion date: Jun 2017 --> Nov 2015 Recruiting --> Completed
- Trial completion: PESS: Pediatric Enhanced Surveillance Study (clinicaltrials.gov) - Dec 5, 2015
P=N/A, N=396, Completed, Sponsor: Columbia University
Recruiting --> Completed Active, not recruiting --> Completed
- carboplatin / Generic mfg., pemetrexed / Generic mfg.
Enrollment closed, Metastases: CHIVA: Chemotherapy for Lung Cancer in HIV-positive Patients (clinicaltrials.gov) - Dec 5, 2015
P2, N=62, Active, not recruiting, Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Complera (emtricitabine/rilpivirine/tenofovir) / Gilead, J&J
Trial completion, Compliance: Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=33, Completed, Sponsor: Prema Menezes, PhD, PA-C
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial completion: PUSH: Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART) (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=185, Completed, Sponsor: University of Washington
Active, not recruiting --> Completed Recruiting --> Completed | N=360 --> 185 | Trial primary completion date: Mar 2016 --> Nov 2015 | Recruiting --> Completed
- Trial primary completion date: BRM4: The Effect of an Enhanced Rice Bran Nutritional Supplement in HIV (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: University of Miami
Recruiting --> Completed | N=360 --> 185 | Trial primary completion date: Mar 2016 --> Nov 2015 | Recruiting --> Completed Trial primary completion date: Jan 2016 --> Jun 2016
- Trial primary completion date: DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=210, Recruiting, Sponsor: University of Delaware
Trial primary completion date: Jan 2016 --> Jun 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- Neupogen (filgrastim) / Kyowa Kirin, Amgen, plerixafor / Generic mfg.
Trial initiation date: HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection (clinicaltrials.gov) - Dec 4, 2015
P1, N=13, Not yet recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Trial primary completion date: Jun 2015 --> Jun 2016 Initiation date: Jun 2015 --> Mar 2016
- emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
Trial initiation date, Trial primary completion date: PrEP-India: Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India (clinicaltrials.gov) - Dec 4, 2015
P0, N=2000, Not yet recruiting, Sponsor: University of Manitoba
Initiation date: Jun 2015 --> Mar 2016 Initiation date: Apr 2015 --> Apr 2016 | Trial primary completion date: Mar 2017 --> Jun 2018
- |||| Isentress (raltegravir) / Merck (MSD)
Trial completion, Combination therapy: Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) (clinicaltrials.gov) - Dec 3, 2015
P2, N=179, Completed, Sponsor: Merck Sharp & Dohme Corp.
Initiation date: Apr 2015 --> Apr 2016 | Trial primary completion date: Mar 2017 --> Jun 2018 No longer recruiting --> Completed
- | lopinavir/ritonavir / Generic mfg.
Trial completion: Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women (clinicaltrials.gov) - Dec 3, 2015
P=N/A, N=116, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- metformin / Generic mfg.
Trial initiation date, Trial primary completion date: Improving Fibrosis Outcomes With Metformin (clinicaltrials.gov) - Nov 19, 2015
P2, N=60, Not yet recruiting, Sponsor: Ottawa Hospital Research Institute
Active, not recruiting --> Completed Initiation date: Jan 2015 --> Jan 2016 | Trial primary completion date: Sep 2016 --> Sep 2017
- Tivicay (dolutegravir) / ViiV Healthcare
Enrollment closed, Adherence: dPEP: The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis (clinicaltrials.gov) - Nov 19, 2015
P4, N=100, Active, not recruiting, Sponsor: Andrew Carr
Initiation date: Jan 2015 --> Jan 2016 | Trial primary completion date: Sep 2016 --> Sep 2017 Recruiting --> Active, not recruiting
- Enrollment closed: Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort (clinicaltrials.gov) - Nov 19, 2015
P=N/A, N=250, Active, not recruiting, Sponsor: Boston Medical Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- nevirapine / Generic mfg.
Trial completion, Trial primary completion date: Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection (clinicaltrials.gov) - Nov 19, 2015
P3, N=27, Completed, Sponsor: The Hospital for Sick Children
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Feb 2016 --> May 2015
- Trial completion, Cytology: Anal HPV Infection and Abnormal Cytology in HIV-infected Women (clinicaltrials.gov) - Nov 17, 2015
P=N/A, N=100, Completed, Sponsor: Boston Medical Center
Recruiting --> Completed | Trial primary completion date: Feb 2016 --> May 2015 Active, not recruiting --> Completed
- Enrollment closed, IO biomarker: The VMVN Study: Virological Monitoring in Viet Nam (clinicaltrials.gov) - Nov 16, 2015
P=N/A, N=650, Active, not recruiting, Sponsor: Beth Israel Deaconess Medical Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting